Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)
Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –
Actinium Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Actinium Pharmaceuticals's total debt was $900.00K at Dec 31, 2019. For fiscal 2019 it was $900.00K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $900.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $900.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $100.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $300.00K | – |
| Q1 FY2019 | Mar 31, 2019 | $200.00K | – |
See a number that looks wrong?